It suppresses B cell receptor (BCR)-mediated activation (63, 64) and human cord blood-derived stem cells directly regulate activated B cells through a galectin-9 mediated mechanism, leading to decreased proliferation and altered phenotypes (65).The significance of galectin-9 in kidney diseases is becoming increasingly clear. This evidence concerns the gene LGALS9 and kidney disorder.